Target intelligence / Profile preview

Partially degraded collagen and necrotic dentin matrix proteins

Molecular classification
Other (extracellular matrix protein fragments), Not a canonical receptor, enzyme, transporter, or classical therapeutic target class
01

Overview

Partially degraded collagen and necrotic dentin matrix proteins comprise a collection of extracellular matrix fragments produced when dentin is exposed to collagenases (e.g., host-derived matrix metalloproteinases or microbial enzymes) and necrotic processes. The mixture includes collagen type I, III, V fragments; degraded non-collagenous proteins like dentin sialophosphoprotein (DSPP), dentin matrix protein 1 (DMP1), osteopontin, glycoproteins, and proteoglycans. These fragments lose normal structural/mineralization functions and may instead act as damage-associated molecular patterns (DAMPs), contribute to inflammation, modulate pulp cell activity, or release sequestered growth factors. They are not a singular, druggable entity but serve as indicators of tissue pathology and remodeling in dental disease.

Other names
Degraded dentin matrix proteinsCollagen fragmentsNecrotic dentin ECM proteinsDenatured dentin proteins
02

Mechanism of action

Not applicable for this fragmented mixture itself. Drugs targeting ECM degradation (e.g., MMP inhibitors) work by inhibiting enzymatic breakdown of matrix proteins, thus reducing the generation of such fragments.

03

Biological functions

Structural support (prior to degradation)Regulate mineralization (prior to degradation)Cell signaling through release of matrix-bound growth factors and chemotactic peptides upon degradationImmune activation (degradation products may trigger inflammation)Matrix remodeling
04

Disease associations

Caries progressionInflammationPulp and periapical tissue response (e.g. wound healing, tertiary dentinogenesis)Tissue necrosis in dental pathology
05

Safety considerations

Not directly applicable, as this is not a druggable target but a pathological indicatorHowever, excessive degradation may impair dental bonding and restoration longevity or stimulate pathological pulp responses
06

Interacting drugs

Matrix metalloproteinase inhibitors (e.g., chlorhexidine)
07

Biomarkers

There are no standardized, clinically used biomarkers to detect "partially degraded collagen and necrotic dentin matrix proteins" directly; however, presence of denatured collagen or released NCPs can indicate matrix degradation and caries activity in research.

Beyond the preview

Go deeper on Partially degraded collagen and necrotic dentin matrix proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Partially degraded collagen and necrotic dentin matrix proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call